Efficacy of a dual task protocol on neurophysiological and clinical outcomes in migraine: a randomized control trial
Neurological Sciences · 2024
DOI: 10.1007/s10072-024-07611-8 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Neurological Sciences, 2024. Verfasst von Manuela Deodato und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Life Sciences, University of Trieste, Trieste, Italy. mdeodato@units.it. Hauptthemen laut MEDLINE: Exercise Therapy, Migraine Disorders. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Università degli Studi di Trieste.
Abstract (Originalsprache)
The main aim of this study was to investigate the efficacy of a dual task protocol in people with episodic migraine with respect to both active exercises only and cognitive task only treatments, concerning some neurophysiological and clinical outcomes. A randomized control trial was adopted in people with episodic migraine without aura. Some neurophysiological and clinical outcomes were collected (t0): resting motor threshold (rMT), short intracortical inhibition (SICI) and facilitation (ICF), pressure pain threshold (PPT), trail making test (TMT), frontal assessment battery (FAB), headache-related disability (MIDAS) and headache parameters. Then, participants were randomized into three groups: active exercise only (n = 10), cognitive task only (n = 10) and dual task protocol (n = 10). After 3 months of each treatment and after 1-month follow-up the same neurophysiological and clinical outcomes were revaluated. A significant time x group effect was only found for the trapezius muscle (p = 0.012, pη2 = 0.210), suggesting that PPT increased significantly only in active exercise and dual task protocol groups. A significant time effect was found for rMT (p < 0.001, pη2 = 0.473), MIDAS (p < 0.001, pη2 = 0.426), TMT (p < 0.001, pη2 = 0.338) and FAB (p < 0.001, pη2 = 0.462). A repeated measures ANOVA for SICI at 3 ms highlighted a statistically significant time effect for the dual task group (p < 0.001, pη2 = 0.629), but not for the active exercises group (p = 0.565, pη2 = 0.061), and for the cognitive training (p = 0.357, pη2 = 0.108). The dual task protocol seems to have a more evident effect on both habituation and sensitization outcomes than the two monotherapies taken alone in people with migraine.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Life Sciences, University of Trieste, Trieste, Italy. mdeodato@units.it.
- Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy. mdeodato@units.it.
- Azienda Sanitaria Universitaria Giuliano Isontina, Via Pascoli 31, 34100, Trieste, Italy. mdeodato@units.it.
- Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
- Azienda Sanitaria Universitaria Giuliano Isontina, Via Pascoli 31, 34100, Trieste, Italy.
- Azienda Sanitaria Universitaria Giuliano Isontina, Strada Di Fiume 447, 34149, Trieste, Italy.
Förderung
- Università degli Studi di Trieste
Zitieren
APA
Deodato, M., Granato, A., Buoite Stella, A., Martini, M., Marchetti, E., Lise, I., Galmonte, A., Murena, L., & Manganotti, P. (2024). Efficacy of a dual task protocol on neurophysiological and clinical outcomes in migraine: a randomized control trial. Neurological Sciences. https://doi.org/10.1007/s10072-024-07611-8
Vancouver
Deodato M, Granato A, Buoite Stella A, Martini M, Marchetti E, Lise I, et al. Efficacy of a dual task protocol on neurophysiological and clinical outcomes in migraine: a randomized control trial. Neurological Sciences. 2024. doi:10.1007/s10072-024-07611-8
BibTeX
@article{Deodato2024,
author = {Deodato, Manuela and Granato, Antonio and Buoite Stella, Alex and Martini, Miriam and Marchetti, Enrico and Lise, Ilaria and Galmonte, Alessandra and Murena, Luigi and Manganotti, Paolo},
title = {Efficacy of a dual task protocol on neurophysiological and clinical outcomes in migraine: a randomized control trial},
journal = {Neurological Sciences},
year = {2024},
doi = {10.1007/s10072-024-07611-8}
}
EUVIMED